title: Survival benefit from up-front fluorouracil, leucovorin, and irinotecan/cetuximab in metastatic colorectal cancer: is it just a now-or-never result?
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Rother
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male
chemical_list: D000911:Antibodies, Monoclonal